Nautilus Historical Cash Flow
| NAUT Stock | USD 2.12 0.01 0.47% |
Analysis of Nautilus Biotechnology cash flow over time is an excellent tool to project Nautilus Biotechnology future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Total Cash From Financing Activities of 349.6 K or End Period Cash Flow of 19.4 M as it is a great indicator of Nautilus Biotechnology ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Nautilus Biotechnology latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Nautilus Biotechnology is a good buy for the upcoming year.
Nautilus |
About Nautilus Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Nautilus balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Nautilus's non-liquid assets can be easily converted into cash.
Nautilus Biotechnology Cash Flow Chart
Add Fundamental
Free Cash Flow
The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Nautilus Biotechnology financial statement analysis. It represents the amount of money remaining after all of Nautilus Biotechnology operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Most accounts from Nautilus Biotechnology's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Nautilus Biotechnology current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nautilus Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. For more information on how to buy Nautilus Stock please use our How to Invest in Nautilus Biotechnology guide.Change To Netincome is likely to gain to about 12.5 M in 2024, whereas Sale Purchase Of Stock is likely to drop slightly above 250.8 K in 2024.
Nautilus Biotechnology cash flow statement Correlations
Click cells to compare fundamentals
Nautilus Biotechnology Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Nautilus Biotechnology cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Sale Purchase Of Stock | (874.3K) | 154.5M | (8.0M) | 232K | 264K | 250.8K | |
| Change In Cash | (1.2B) | 36.6M | 149.2M | (71.0M) | (95.1M) | (99.8M) | |
| Free Cash Flow | (10.6M) | (14.9M) | (41.5M) | (48.1M) | (54.2M) | (56.9M) | |
| Change In Working Capital | (545K) | (1.4M) | (22K) | (788K) | (3.2M) | (3.1M) | |
| Other Cashflows From Financing Activities | 36K | 75.9M | 327.4M | 562K | 368K | 349.6K | |
| Other Non Cash Items | (157K) | 295K | 320K | (890K) | (2.7M) | (2.8M) | |
| Capital Expenditures | 926K | 921K | 2.3M | 2.3M | 2.4M | 1.6M | |
| Total Cash From Operating Activities | (9.7M) | (14.0M) | (39.2M) | (45.8M) | (51.7M) | (54.3M) | |
| Net Income | (9.6M) | (15.6M) | (50.3M) | (57.9M) | (63.7M) | (60.5M) | |
| Total Cash From Financing Activities | 36K | 75.9M | 327.4M | 562K | 368K | 349.6K | |
| End Period Cash Flow | 595K | 37.2M | 186.5M | 115.5M | 20.4M | 19.4M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Nautilus Stock Analysis
When running Nautilus Biotechnology's price analysis, check to measure Nautilus Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nautilus Biotechnology is operating at the current time. Most of Nautilus Biotechnology's value examination focuses on studying past and present price action to predict the probability of Nautilus Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nautilus Biotechnology's price. Additionally, you may evaluate how the addition of Nautilus Biotechnology to your portfolios can decrease your overall portfolio volatility.